Trial Profile
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Bevacizumab
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 26 Apr 2017 Status changed from recruiting to completed.
- 11 Apr 2012 New trial record